Global Custom Market Research Reports Provider Company

phone

Ajanta Pharma Ltd (AJANTPHARM) - Financial and Strategic SWOT Analysis Review

  • Published Date: 29 Aug 2018
  • Number of Pages: 47
  • Category: SWOT Analysis
  • Country: India
Ajanta Pharma Ltd (AJANTPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ajanta Pharma Ltd (Ajanta Pharma) is a specialty pharmaceutical company, which focuses on the research, manufacture and commercialization of finished dosages in domestic and international markets. The company has a presence in cardiology, pain management, dermatology and ophthalmology therapy areas. It provides generics in developed markets of USA and branded generics in emerging countries such as India, Africa, CIS, Middle East and South East Asia. Ajanta Pharma also supplies multivitamins, eye drops, cough syrups and antibiotics to government bodies in India; and anti-malarial products to Africa and Global Fund. It operates subsidiaries in Mauritius, Philippines, Nigeria, the US and the UK. Ajanta Pharma is headquartered in Mumbai, Maharashtra, India.

Ajanta Pharma Ltd Key Recent Developments

Jul 31,2018: Ajanta Pharma reports Q1 FY 2019 consolidated result
Jul 27,2018: Ajanta Pharma: Update on US FDA inspection
Jul 13,2018: National drug regulator finds illegal manufacturing at Pondy firm
May 02,2018: Ajanta Pharma reports Q4 FY 2018 Consolidated Result
Jan 25,2018: Ajanta Pharma: Q3 Income from Operations at Rs. 587 cr., PAT at Rs. 147 cr.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData

3
List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Ajanta Pharma Ltd - Key Facts 6
Ajanta Pharma Ltd - Key Employees 7
Ajanta Pharma Ltd - Key Employee Biographies 8
Ajanta Pharma Ltd - Major Products and Services 9
Ajanta Pharma Ltd - History 10
Ajanta Pharma Ltd - Company Statement 12
Ajanta Pharma Ltd - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 Company Analysis 14
Company Overview 14
Ajanta Pharma Ltd - Business Description 15
Ajanta Pharma Ltd - Corporate Strategy 16
Ajanta Pharma Ltd - SWOT Analysis 17
SWOT Analysis - Overview 17
Ajanta Pharma Ltd - Strengths 17
Ajanta Pharma Ltd - Weaknesses 18
Ajanta Pharma Ltd - Opportunities 19
Ajanta Pharma Ltd - Threats 20
Ajanta Pharma Ltd - Key Competitors 21
Section 3 Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios - Interim Ratios 27
Financial Ratios - Ratio Charts 28
Section 4 Companys Lifesciences Financial Deals and Alliances 29
Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Ajanta Pharma Ltd, Recent Deals Summary 31
Section 5 Companys Recent Developments 32
Jul 31, 2018: Ajanta Pharma reports Q1 FY 2019 consolidated result 32
Jul 27, 2018: Ajanta Pharma: Update on US FDA inspection 34
May 02, 2018: Ajanta Pharma reports Q4 FY 2018 Consolidated Result 35
Jan 25, 2018: Ajanta Pharma: Q3 Income from Operations at Rs. 587 cr., PAT at Rs. 147 cr. 36
Jan 25, 2018: Ajanta Pharma reports Q3 FY 2018 Consolidated Result 37
Dec 15, 2017: Ajanta Pharma: Change in designation of a Director 38
Aug 09, 2017: Ajanta Pharma: Income from Operations at Rs. 473 cr., PAT at Rs. 95 cr 39
Apr 10, 2017: Ajanta Pharma Provides Update On US FDA Inspection At Dahej Formulation Facility 40
Feb 09, 2017: Ajanta Pharma Provides Update On US FDA Inspection 41
Jan 24, 2017: Ajanta Pharma Announces No import alert on us by US FDA 42
Section 6 Appendix 43
Methodology 43
Ratio Definitions 43
About GlobalData 47
Contact Us 47
Disclaimer 47

List Of Tables


Ajanta Pharma Ltd, Key Facts 6
Ajanta Pharma Ltd, Key Employees 7
Ajanta Pharma Ltd, Key Employee Biographies 8
Ajanta Pharma Ltd, Major Products and Services 9
Ajanta Pharma Ltd, History 10
Ajanta Pharma Ltd, Subsidiaries 13
Ajanta Pharma Ltd, Key Competitors 21
Ajanta Pharma Ltd, Ratios based on current share price 22
Ajanta Pharma Ltd, Annual Ratios 23
Ajanta Pharma Ltd, Annual Ratios (Cont...1) 24
Ajanta Pharma Ltd, Annual Ratios (Cont...2) 25
Ajanta Pharma Ltd, Interim Ratios 27
Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Ajanta Pharma Ltd, Recent Deals Summary 31
Currency Codes 43
Capital Market Ratios 43
Equity Ratios 44
Profitability Ratios 44
Cost Ratios 45
Liquidity Ratios 45
Leverage Ratios 46
Efficiency Ratios 46

List Of Figures


Ajanta Pharma Ltd, Performance Chart (2014 - 2018) 26
Ajanta Pharma Ltd, Ratio Charts 28
Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

Copa Holdings, S.A. (CPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

Rakuten Inc (4755) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report

Screen Holdings Co., Ltd. (7735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports